The Role of Prophylactic or Adjuvant Hyperthermic Intraperitoneal Therapy in Appendiceal and Colorectal Cancer Peritoneal Metastasis

Surg Oncol Clin N Am. 2025 Apr;34(2):227-240. doi: 10.1016/j.soc.2024.12.001. Epub 2025 Jan 7.

Abstract

Appendiceal neoplasms and colorectal cancer have a propensity to develop peritoneal metastases. Despite advancements in systemic therapy and surgical management, the development and management of peritoneal metastases remains a challenging problem. Utilization of adjuvant or prophylactic hyperthermic intraperitoneal chemotherapy has been described, with varying quality of data and reported outcomes. The utilization of prophylactic or adjuvant hyperthermic intraperitoneal chemotherapy in patients with appendiceal neoplasms and colorectal cancer remains an active area of exploration.

Keywords: Adjuvant; Appendiceal neoplasm; Colorectal cancer; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Prophylactic.

Publication types

  • Review

MeSH terms

  • Appendiceal Neoplasms* / pathology
  • Appendiceal Neoplasms* / therapy
  • Chemotherapy, Adjuvant
  • Colorectal Neoplasms* / pathology
  • Colorectal Neoplasms* / therapy
  • Combined Modality Therapy
  • Humans
  • Hyperthermia, Induced*
  • Hyperthermic Intraperitoneal Chemotherapy* / methods
  • Peritoneal Neoplasms* / prevention & control
  • Peritoneal Neoplasms* / secondary
  • Peritoneal Neoplasms* / therapy